Dentis Co Ltd

Dentis Co Ltd maintains a debt-to-equity ratio of 1.41, indicating a moderate reliance on debt financing, and a current ratio of 0.93, suggesting limited short-term liquidity. The company's price-to-book ratio of 0.89 and price-to-tangible-book ratio of 0.89 imply that the market values the company below its book value, potentially signaling undervaluation or asset-heavy operations. The enterprise value to EBITDA ratio of 91.70 is significantly high, suggesting a premium valuation relative to earnings.

The company's return on equity of 5.43% and return on assets of 1.58% are below the industry median for Medical Equipment, Supplies & Distribution, indicating weaker profitability and asset utilization compared to peers. Gross profit of KRW 14,106,124,980 and operating income of KRW 1,424,673,910 suggest a narrow margin structure, which may limit resilience during economic downturns.

Dentis Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification, exposing the company to regional economic and regulatory risks. The lack of segmental or geographic breakdown in the financials limits visibility into potential growth or risk areas.

The company's revenue of KRW 28,571,625,780 in the latest period reflects a stable but non-expansive growth trajectory. The outlook for the current fiscal year does not indicate significant revenue acceleration, with free cash flow at -KRW 5,047,337,830 and capital expenditure at -KRW 9,039,416,840, suggesting reinvestment rather than surplus cash generation.

The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or respond to unexpected events. No dilution sources are identified in the latest filings, and the dilution potential remains low.

Recent filings and transcripts do not disclose material events or strategic shifts. The company's financials and risk profile remain consistent with prior periods, with no significant changes in operations or capital structure.

Revenue grew at a 14.8% CAGR over four years, demonstrating consistent top-line expansion despite recent volatility.

Return on equity of 5.4% significantly outperforms the cohort median of 1.4%, reflecting efficient capital utilization.

Dilution risk is assessed as low, providing some protection to existing shareholders against equity erosion.

Debt-to-equity ratio of 1.41 is in the bottom quartile of the cohort, indicating excessive leverage and financial risk.

High credit risk and medium liquidity risk flags suggest potential difficulties in meeting financial obligations.

Revenue KRW 87.09B, +32,5% YoY; Operating income +1 418,3% YoY.

• ▍Revenue KRW 87.09B, +32,5% YoY
• ▍Operating income +1 418,3% YoY
• ▍Net income +102,6% YoY
• ▍Free cash flow +66,7% YoY
• ▍Net margin 1.4%

Revenue KRW 65.74B; Operating income KRW 367.0M.

• ▍Revenue KRW 65.74B
• ▍Operating income KRW 367.0M
• ▍Net margin 0.9%